Press Releases

Scipio bioscience Announces a Single-Cell Grant Program for Four Researchers to Receive a Complete 3′ scRNA-seq Solution Valued up to US$30,000

Scipio bioscience has announced a grant program for researchers to receive a complete 3′ scRNA-seq solution valued at up to US$30,000.

CD ComputaBio Introduces PyMOL Software for Bioinformatics Analysis

Pronalyse’s Fusion Protein Characterization Service Aids in the Drug Development Process

Creative Proteomics Lipidomics Launches Ceramides Analysis Service

Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service

Dolomite Bio launches RNAdia 2.0 Reagent Kit – Fast, Easy, Robust

Dolomite Bio has announced the launch of the RNAdia 2.0 reagent kit for single cell research. At a significantly lower cost compared to competitor reagents the new and improved RNAdia 2.0 kit alleviates that stress, allowing researchers to focus on what is important, doing more and discovering more.

UK Supplier expands to provide Chemically Defined & Serum-Free Cell Media Solutions for the Cell and Gene Therapy Industry

BioPharma Dynamics has announced the expansion of its extensive portfolio to offer a range of chemically defined T-Cell Media, DMSO-Free Cryopreservation Solutions, and Recombinant Growth Factors, for the Cell & Gene Therapy market.

Biopharma PEG Develops PEG Products For Click Chemistry

Huateng Pharma Supplies Semaglutide Intermediates Against Type 2 Diabetes

Genezen appoints Chief Commercial Officer to Executive Leadership Team

Genezen appoints Jeff Whitmore as CCO

Andelyn Biosciences to Manufacture First Gene Therapy for Infantile Neuroaxonal Dystrophy in the US

Creative Enzymes Expands Its Service Offering with the Launch of Custom Enzyme Blends

Creative Enzymes Provides DNA Molecular Weight Markers and Ladders

CD Genomics Expands Its Sequencing Portfolio with the Launch of Whole Exome Sequencing

MicrobioSeq Boosts Scientific Research with Gene Expression Analysis

Micro-Sphere Launches New Research & Development Services at Swiss Site

Global contract development and manufacturing organisation (CDMO) Micro-Sphere has launched a new, 200 square-foot research and development (R&D) lab to strengthen its services in formulation development and inhalation.

Zebrafish Disease Model: Developed by Creative Biogene to Support Multiple Therapeutic Areas

IntegrateRNA Develops Premade Circular RNA Products to Satisfy Various Downstream Applications

Microbiosci Develops Data-independent Acquisition Proteomics to Support Molecular Diagnostics

Creative Bioarray Develops More Than 1000 Cell Types Together with Selective Cell Culture Media